Healio

Enzyme replacement therapy curbs bleeding events in congenital blood clotting disorder

Please provide your email address to receive an email when new articles are posted on . Mean maximum ADAMTS13 activity after recombinant ADAMTS13 exceeded 100%. Markedly fewer patients receiving ...
FiercePharma

Takeda scores second FDA approval this week with green light for rare blood clotting disorder drug Adzynma

Thanks to a Takeda approval Thursday, patients now have a drug to tackle a rare inherited blood clotting disorder. The U.S. FDA has given a green light to Takeda’s Adzynma, the first recombinant ...
Yahoo

Takeda Pharma gets US FDA approval for rare blood disorder therapy

(Reuters) -The U.S. Food and Drug Administration on Thursday approved Takeda Pharmaceutical's therapy to treat a rare genetic blood disorder in adult and pediatric patients. Takeda's Adzynma becomes ...
WWLTV

FDA approves first treatment for rare blood disorder in pediatric patients 12 and older

WASHINGTON — The Food and Drug Administration has approved the first drug treatment for pediatric patients 12 and older with a rare blood disorder. The treatment for acquired thrombotic ...